DOCSLIB.ORG

HEALTHCARE Transforming the Healthcare Supply Chain Supplychain Through Best Practices for Processes and Data COLLABORATIVE Three Co-Located Events

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HEALTHCARE Transforming the Healthcare Supply Chain Supplychain Through Best Practices for Processes and Data COLLABORATIVE Three Co-Located Events HEALTHCARE Transforming The Healthcare Supply Chain SupplyChain Through Best Practices For Processes And Data COLLABORATIVE Three Co-Located Events Learn and advance the standard practices for improving contract efficiency, CONTRACT achieving pricing accuracy, and eliminating rework. EDUCATIONAL ADMINISTRATION Who Should Attend FOUNDATION CONFERENCE Anyone involved in contract administration, national accounts or contract negotiations, pricing management, rebate/chargeback management, IT, February 4–5, 2020 finance, or other related areas. Discuss approaches to improve patient care by ensuring product availability HEALTHCARE SUPPLY CHAIN through improved supply chain visibility and supply/demand management. SupplyChain VISIBILITY COLLABORATIVE Who Should Attend CONFERENCE Supply chain professionals, demand planners and forecasters, operations leaders, inventory management, S&OP professionals, national accounts February 5–6, 2020 leaders, anyone else interested in supply and demand planning. Explore ways to leverage current and future e-commerce and product information management capabilities to grow your business. Who Should Attend Marketing professionals, e-commerce leaders, CIOs and IT managers, product managers, owners and CEOs, anyone else involved in e-commerce, February 5–6, 2020 digital marketing, or product information management (PIM). Hyatt Regency Coral Gables Register Today Coral Gables, Florida HIDA.org HEALTHCARE Custom sponsorship packages available. SupplyChain Contact Julie Berry at 703-838-6103 or [email protected]. COLLABORATIVE Sponsorship Opportunities Exhibit Opportunities Gain visibility to more than 300 conference participants at Presenting Sponsor ..................... $10,000 (member only) three co-located events focusing on e-commerce capabilities, Includes three registrations, exhibit table, session contract efficiency and demand planning. introduction; and recognition in marketing, web, and onsite slides/signage. Back of Badges Sponsor ........................................ $2,500 Sponsor ........... $3,950 (member) | $6,500 (non-member) Nightly Schedule of Events Email Sponsor ............... $3,000 Includes two registrations, exhibit table, recognition in Education Session Sponsor ..................................... $3,500 marketing, web, and onsite slides/signage. Reception Sponsor ................................................. $4,500 Supporter......... $2,750 (member) | $5,500 (non-member) Interested in multiple sponsorship packages? Includes one registration, exhibit table, recognition in Contact Julie Berry for a customized package. marketing, web, and onsite slides/signage. Contract Administration Conference Attending Companies (2017, 2018 & 2019) 3M Health Care Carolinas HeathCare Systems HD Supply Facilities Maintenance Medline Industries, Inc. Siemens Healthineers Abbott Nutrition Claflin Company Healthcare Supply Chain MedProcure Sloan Medical AdvantageTrust CME Association (HSCA) Medtronic Smith & Nephew AdventHealth Coloplast Corp. Henry Schein, Inc. Mercedes Scientific SourceMark, LLC AliMed, Inc. Concordance Healthcare Solutions HillRom Mercury Medical SPS Commerce, Inc. Alliant Purchasing ConvaTec Hologic, Inc. Midmark Corporation STERIS Corporation American Medical Depot Dale Medical Products HTL-STREFA Inc. MMCAP Infuse Stryker AmerisourceBergen Definitive Healthcare, LLC Innovative Healthcare Corporation Model N Symmetry Surgical Ansell Healthcare DeRoyal Innovatix MSISI TECSYS Aspen Surgical (Formerly DJO, Inc. Intalere NDC, Inc. Teleflex Medical STERION Inc.) Encompass Group Johnson & Johnson Health Care Nestle Health Science Terumo Medical Corporation Avanos Medical, Inc Essentia Health Systems Ntara Thermo Fisher Scientific B. Braun Medical Essity HMS North America Key Surgical, Inc. Optimal TIDI Products BD First Quality Products Lifeline Pharmaceuticals, LLC Owens & Minor Turenne PharMedCo, Inc. Beckman Coulter Geisinger Health System LivaNova PDI TwinMed Medical Supplies and Bemis Healthcare Global Healthcare Exchange Lynn Medical, Inc. Posey Company Services Benco Dental GOJO Industries Mayo Clinic Premier, Inc. ValueCentric BSN Medical Graham Medical McKesson Corporation PROS VaxServe C. R. Bard, Inc. GroveMed McKesson Medical-Surgical Provista Vistex Captis GS1 US Medegen Medical Products Roche Diagnostics Vizient Cardinal Health Hashed Health Medela, Inc. Sempermed USA Supply Chain Visibility Conference Attending Companies (2019) 3M Health Care First Quality Products Johnson & Johnson Health Care PDI TwinMed Medical Supplies Alleer Training & Consulting Global Biomedical Technologies Systems Preferred Medical and Services B. Braun Medical Global Healthcare Exchange Loma Linda University Medical Ron Denton & Associates UAB Medicine BD HealthCare Transparency Center SAS Institute Inc. UT Medical Center Cardinal Health Initiative Mayo Clinic STERIS Corporation ValueCentric Claflin Company Henry Schein, Inc. McKesson Medical-Surgical Strategic Marketplace Initiative Vizient ETHICON, Inc. HF Acquisition Co., LLC Medline Industries, Inc. The Stevens Company Limited Vuemed HORIBA Medical Nestle Health Science TIDI Products E-Commerce & Digital Strategies Conference Attending Companies (2018 & 2019) 3M Health Care CME Global Healthcare Exchange Medline Industries, Inc. Sekisui Diagnostics Amazon Professional Healthcare Content4Commerce GOJO Industries Molnlycke Health Care Siemens Healthineers B. Braun Medical Dale Medical Products Graham-Field Health Products NDC, Inc. Smith & Nephew B2B E-Commerce Digital Commerce Group Hashed Health Nestle Health Science Smiths Medical North America B2X Partners Domtar Personal Care HD Supply Facilities Maintenance Online Tech Strategic Market Alliance (SMA) BD Dotmailer Henry Schein, Inc. OroCommerce Surgo Surgical Supply Ben E. Keith Company E7 Solutions HillRom PDI Teleflex Medical Benco Dental ECO Sound Medical Services HORIBA Medical Performance Health Terumo Medical Corporation C. R. Bard, Inc. ES Tech Group IMCO Home Care Precision Surgical Inc. The Brewer Company Cardinal Health Essity HMS North America Johnson Johnson Health Care Premier, Inc. The Clorox Company Claflin Company ETHICON, Inc. KBK Communications Quidel Corporation The Stevens Company Limited Clint Pharmaceuticals First Quality Products Kinesio Taping Reliance Wholesale, Inc. TIDI Products Clock Medical Supply, Inc. Gericare Medical Supply McKesson Medical-Surgical Saalfeld Redistribution Turenne PharMedCo, Inc. Global Biomedical Technologies MediSouth, Inc. SCHILLER Americas Inc..
Load more

Recommended publications
  • HEALTH BENEFITS Providing Value for Our Employees
    HEALTH BENEFITS Providing Value for Our Employees March 2017 Business Roundtable CEO members lead companies with more than $6 trillion in annual revenues and nearly 15 million employees. The combined market capitalization of Business Roundtable member companies is the equivalent of nearly one-quarter of total U.S. stock market capitalization, and Business Roundtable members invest $103 billion annually in research and development — equal to 30 percent of U.S. private R&D spending. Our companies pay $226 billion in dividends to shareholders and generate $412 billion in revenues for small and medium-sized businesses annually. Business Roundtable companies also make more than $7 billion a year in charitable contributions. Please visit us at www.brt.org, check us out on Facebook and LinkedIn, and follow us on Twitter. Copyright © 2017 by Business Roundtable HEALTH BENEFITS Providing Value for Our Employees March 2017 March 2017 DEAR BUSINESS LEADERS AND STAKEHOLDERS: I am pleased to share with you a new report highlighting what leading U.S. companies are doing to improve health outcomes for our employees and their families. America’s employer-sponsored health benefits system is the foundation of health care in the United States. Of the 209 million Americans who are covered by health insurance plans, 85 percent — or 177 million Americans* — receive health coverage through an employer. This report demonstrates many different ways employers are helping to drive a health care system that delivers better health care quality and value. I hope you find this report helpful. Sincerely, Brian Moynihan Chairman and Chief Executive Officer Bank of America * Bureau of Labor Statistics, Health Insurance Coverage in the United States: 2015, Current Population Reports, September 2016.
    [Show full text]
  • Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Inc
    Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Gathering Momentum Company Overview Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives. Valeant’s primary focus is principally in the areas of dermatology and neurology. The Company’s growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and build on the company’s strength in dermatology and neurology. Valeant plans to strategically expand its pipeline by adding new compounds or products through product or company acquisitions and will maximize its pipeline through strategic partnering to optimize its research and development assets and strengthen ongoing internal development capabilities. Valeant’s strategic markets are primarily in the United States, Canada, Central and Eastern Europe, Latin America, Australia and South East Asia. Headquartered in Montreal, Quebec, Valeant has approximately 7,000 employees worldwide. FORWARD-LOOKING Statements In addition to current and historical information, this Annual Report contains forward-looking statements, including, without limitation, statements regarding our strategy, expected future revenue, the prospects for approval of product candidates and the timing of regulatory approvals, and the growth and future development of the company, its business units and its products. Words such as “expects,” “anticipates,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” or similar language identify forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties. Our actual results may differ materially from those contemplated by the forward-looking statements.
    [Show full text]
  • Mckesson CORPORATION
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ‘ Filed by a Party other than the Registrant Check the appropriate box: ‘ Preliminary Proxy Statement ‘ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2)) Definitive Proxy Statement ‘ Definitive Additional Materials ‘ Soliciting Material Pursuant to §240.14a-12 McKESSON CORPORATION (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. ‘ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: ‘ Fee paid previously with preliminary materials. ‘ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: A LETTER FROM OUR INDEPENDENT CHAIR Dear Fellow Shareholders, First and foremost, on behalf of the Board of Directors, I would like to thank you for your investment in McKesson and for the confidence you place in this Board to oversee your interests in our Company particularly through the most unprecedented global health crisis in modern history.
    [Show full text]
  • UCLA-Ledgerdomain-PDG
    UCLA-LeDgerDomain: DSCSA Solution Through Blockchain Technology Drug Tracking, Tracing, anD Verification at the Last Mile of the Pharmaceutical Supply Chain with BRUINchain FDA Submitter: Han-Lian William Chien, PharmD, MBA Chief Pharmacy Officer: Josenor “Jess” DeJesus, PharmD, MBA, FACHE Senior Supervising Dispenser: Jennifer Colon, PharmD Prescriber: Prof. Perry B. Shieh, MD,PhD RonalD Reagan UCLA MeDical Center ThanKing Biogen serialization PDG Member & Presenter: Ben Taylor, CEO, LeDgerDomain team leD by Bjoern Rosner, PhD As well as Imran ShaKur PDG FDA Pilot Program Round Robin, July 2020 1 Partnering Entities. UCLA Health UCLA Health’s five facilities & >200 clinics serve 600,000 unique patients yearly UCLA Health Pharmacy’s 300+ staffers support three hospital pharmacies, an infusion pharmacy, two research pharmacies & five retail/specialty pharmacies UCLA partnered with LedgerDomain to build WORKING APP to apply DSCSA requirements to a large hospital pharmacy: the most complex LAST MILE Please take a moment to thank UCLA’s COVID responders 2 Partnering Entities. LedgerDomain Built KitChain for Clinical Supply FDA Naloxone Challenge Blockchain Working Group fda.gov/NewsEvents/PublicHealthFocus/ucm533711.htm Member, Hyperledger Project 3 Pilot Project Key Objectives. Last Mile DSCSA Objectives Assist colleagues to perform robust DSCSA checks & verification Flag double-counts and surface suspect transactions Enforce ground truth with exception handling; gradually escalate to 3911 Provide real-time inventory & quarantine at the
    [Show full text]
  • Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I
    Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I. Imaging Systems Corp A.L.I. Technologies (International) LLC Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Laboratories 100 Abbott Park Rd. Bldg. AP6D-1 Abbott Park IL 60064 Abbott Molecular Division Abbott Nutrition Products Division Abbott Pharmaceutical Products Group Abbott Point of Care Division Abbott Vascular Division Abraxis Bioscience, LLC. 11755 Wilshire Blvd., Suite 2000 Los Angeles CA 90025 Access Diabetic Supply, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Acorda Therapeutics, Inc. 15 Skyline Drive Hawthorne NY 10532 Advanced Neuromodulation Systems, Inc. Advanced Respiratory, Inc. Advanced Sterilization Products 33 Technology Drive Irvine CA 92618 Aesculap Implant Systems, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Alaven Pharmaceuticals, LLC 2260 Northwest parkway Suite A Marietta GA 30067 Alcon Laboratories, Inc. 6201 South Freeway Fort Worth TX 76134 Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire CT 06410 Alkermes, Inc. 88 Sidney Street Cambridge MA 02139 Allen Medical Systems, Inc. Allergan Sales, LLC Allergan USA, Inc. Allergan, Inc. 2525 Dupont Drive Irvine CA 92612 Alpharma Pharmaceuticals, Inc. Alpharma Pharmaceuticals, LLC AMAG Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 AMATECH Corporation American Medical Distributors, Inc. 100 New Highway N Amityville NY 11701 American Medical System,
    [Show full text]
  • Rebateable Manufacturers
    Rebateable Labelers – July 2021 Manufacturers are responsible for updating their eligible drugs and pricing with CMS. Montana Healthcare Programs will not pay for an NDC not updated with CMS. Note: Some manufacturers on this list may have some NDCs that are covered and others that are not. Manufacturer ID Manufacturer Name 00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007 GLAXOSMITHKLINE 00008 WYETH PHARMACEUTICALS LLC, 00009 PHARMACIA AND UPJOHN COMPANY LLC 00013 PFIZER LABORATORIES DIV PFIZER INC 00015 MEAD JOHNSON AND COMPANY 00023 ALLERGAN INC 00024 SANOFI-AVENTIS, US LLC 00025 PFIZER LABORATORIES DIV PFIZER INC 00026 BAYER HEALTHCARE LLC 00032 ABBVIE INC. 00037 MEDA PHARMACEUTICALS, INC. 00039 SANOFI-AVENTIS, US LLC 00046 WYETH PHARMACEUTICALS INC. 00049 ROERIG 00051 ABBVIE INC 00052 ORGANON USA INC. 00053 CSL BEHRING L.L.C. 00054 HIKMA PHARMACEUTICAL USA, INC. 00056 BRISTOL-MYERS SQUIBB PHARMA CO. 00065 ALCON LABORATORIES, INC. 00068 AVENTIS PHARMACEUTICALS 00069 PFIZER LABORATORIES DIV PFIZER INC 00071 PARKE-DAVIS DIV OF PFIZER 00074 ABBVIE INC 00075 AVENTIS PHARMACEUTICALS, INC. 00078 NOVARTIS 00085 SCHERING CORPORATION 00087 BRISTOL-MYERS SQUIBB COMPANY 00088 AVENTIS PHARMACEUTICALS 00093 TEVA PHARMACEUTICALS USA, INC. 00095 BAUSCH HEALTH US, LLC Page 1 of 19 Manufacturer ID Manufacturer Name 00096 PERSON & COVEY, INC. 00113 L. PERRIGO COMPANY 00115 IMPAX GENERICS 00116 XTTRIUM LABORATORIES, INC. 00121 PHARMACEUTICAL ASSOCIATES, INC. 00131 UCB, INC. 00132 C B FLEET COMPANY INC 00143 HIKMA PHARMACEUTICAL USA, INC. 00145 STIEFEL LABORATORIES, INC, 00168 E FOUGERA AND CO. 00169 NOVO NORDISK, INC. 00172 TEVA PHARMACEUTICALS USA, INC 00173 GLAXOSMITHKLINE 00178 MISSION PHARMACAL COMPANY 00185 EON LABS, INC.
    [Show full text]
  • Grossman V. Johnson & Johnson Et Al. Complaint
    Case3:14-cv-03557 Document1 Filed08/06/14 Page1 of 27 1 THOMAS SIMS (SBN 264174) [email protected] 2 RUSSELL BUDD [email protected] 3 BARON & BUDD, P. C. 3102 Oak Lawn Ave, Suite 1100 4 Dallas, Texas 75219 Telephone: (214) 521-3605 5 Facsimile: (214) 520-1181 6 Attorneys for Plaintiff 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 SAN FRANCISCO DIVISION 10 KARYN JOY GROSSMAN; 11 Case No.: _______________3:14-cv-03557 12 Plaintiff, v. 13 COMPLAINT FOR DAMAGES JOHNSON & JOHNSON; JOHNSON & JOHNSON AND 14 PHARMACEUTICAL RESEARCH & DEMAND FOR JURY TRIAL DEVELOPMENT, L.L.C.; ORTHO-MCNEIL- 15 JANSSEN PHARMACEUTICALS, INC.; and 1. Strict Liability 2. Product Liability - Failure to 16 MCKESSON CORPORATION; Warn 17 Defendants. 3. Negligence 4. Breach of Express Warranty 18 5. Breach of Implied Warranty 6. Fraud 19 7. Negligent Representation 8. Fraudulent Concealment 20 21 22 Plaintiff, by and through the undersigned counsel, hereby brings this Complaint for 23 damages against the Defendants, and alleges the following: 24 INTRODUCTION 25 1. This is an action for damages suffered by Plaintiff as a direct and proximate 26 result of Defendants’ negligent and wrongful conduct in connection with the design, 27 development, manufacture, testing, packaging, promoting, marketing, advertising, distribution, 28 1 COMPLAINT Case3:14-cv-03557 Document1 Filed08/06/14 Page2 of 27 1 labeling, and/or sale of the pharmaceutical drug Levaquin® (also known as levofloxacin). 2 Levaquin® in any of its forms shall herein be referred to as “Levaquin.” Plaintiff maintains that 3 Levaquin is defective, dangerous to human health, unfit and unsuitable to be marketed and sold 4 in commerce, and lacked proper warnings and directions as to the dangers associated with its 5 use.
    [Show full text]
  • COVID-19 Vaccine: Product Information Guide Summary
    COVID-19 Vaccine Product Information Guide Vaccination Card Product Information Guide for COVID-19 Vaccines and Associated Products July 26, 2021 CS321629-V 1 COVID-19 Vaccine Product Information Guide Contents Purpose & How To Use This Guide . 3 Centrally Distributed Vaccines and Ancillary Kits: Moderna . 4 Centrally Distributed Vaccines and Ancillary Kits: Janssen . 6 Ancillary Supply Administration Kit: Standard Syringe (Centrally Distributed) . 7 Centrally Distributed Ancillary Supply Kit Volume . 9 Direct-Ship Vaccine and Ancillary Kit: Pfizer-BioNTech . 10 Combined Administration and Mixing Kit-450 (Direct Ship) Pfizer-BioNTech . 12 Large Combined Ancillary Supply Kit for Administration and Mixing (Direct Ship) Pfizer-BioNTech . 14 Dry Ice Kit (Direct Ship) . 16 Contents and Quantities for Mega Kits to Support Pfizer-BioNTech Vaccine . 17 Addendum: COVID-19 Vaccine Ancillary Supply Kit Guidance . 18 Possible Ancillary Kits—COVID-19 Vaccines Supporting 100 Doses (Moderna and Janssen) . 21 Possible Ancillary Kits—COVID-19 Vaccines Supporting 140 Doses (Moderna) . 22 Possible Ancillary Kits—COVID-19 Vaccine Supporting 450 Doses (Pfizer-BioNTech) . 23 Possible Ancillary Kits—COVID-19 Vaccine Supporting 1,170 Doses (Pfizer-BioNTech) . 24 General Needle and Syringe Resources . 25 Specific Ancillary Kit Products and Product Information . 26 Gold Coast CarePoint Safety Needles and Syringes . 31 Gold Coast Easy Touch FlipLock Safety Syringes Brochure . 32 Gold Coast Easy Touch FlipLock Safety Syringes Brochure . 33 Gold Coast Easy Touch Fluringe Fliplock Safety Syringes . 34 HTL Strefa DropSafe Syringe with Safety Needle Instructions for Use . 35 Retractable Technologies Inc VanishPoint® Syringe Flyer . 36 Smiths Medical Needle-Pro® and Needle-Pro® Edge™ Safety Devices . 37 Pfizer-BioNTech COVID-19 Vaccine and Low Dead-Volume (LDV) Syringes and/or Needles .
    [Show full text]
  • Product Information Guide for COVID-19 Vaccines and Associated Products
    Product Information Guide for COVID-19 Vaccines and Associated Products Version 5–February 13, 2021 Contents Product Information Guide Summary ........................................................................................................................2 Centrally Distributed Vaccines and Ancillary Kits .......................................................................................................3 Vaccines (Centrally Distributed) .............................................................................................................................................. 3 Ancillary Supply Administration Kit: Standard Syringe (Centrally Distributed) ....................................................................... 4 Centrally Distributed Ancillary Supply Kit Volume .................................................................................................................. 5 Direct-Ship Vaccine and Ancillary Kit ..........................................................................................................................6 Pfizer Vaccine (Direct Ship) ..................................................................................................................................................... 6 Large Combined Ancillary Supply Kit for Administration and Mixing (Direct Ship) ................................................................. 7 Combined Ancillary Supply Kit for Administration and Mixing (Direct Ship) .......................................................................... 8 Dry
    [Show full text]
  • Opioid Prescriptions Filled in The
    VIRGINIA: IN THE CIRCUIT COURT FOR WISE COUNTY AND THE CITY OF NORTON CITY OF NORTON, VIRGINIA, Plaintiff, v. PURDUE PHARMA, L.P.; PURDUE PHARMA, INC.; THE PURDUE FREDERICK COMPANY, INC.; RHODES PHARMACEUTICALS, L.P.; ABBOTT LABORATORIES; ABBOTT LABORATORIES, INC.; MALLINCKRODT PLC; MALLINCKRODT LLC; ENDO HEALTH SOLUTIONS, INC; ENDO Case No. CL18 - __________ PHARMACEUTICALS, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; Jury Trial Demanded PAR PHARMACEUTICAL, INC.; TEVA PHARMACEUTICALS USA, INC.; CEPHALON, INC.; BARR LABORATORIES, INC.; JANSSEN PHARMACEUTICALS, INC.; ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC.; JANSSEN PHARMACEUTICA, INC.; WATSON LABORATORIES, INC.; ALLERGAN PLC; ACTAVIS PHARMA, INC.; ACTAVIS, LLC; INSYS THERAPEUTICS, INC.; KVK-TECH, INC.; AMNEAL PHARMACEUTICALS LLC; IMPAX LABORATORIES, LLC; AMNEAL PHARMACEUTICALS, INC.; AMNEAL PHARMACEUTICALS OF NEW YORK, LLC; MYLAN PHARMACEUTICALS, INC.; MCKESSON CORPORATION; MCKESSON MEDICAL-SURGICAL INC.; CARDINAL HEALTH, INC.; AMERISOURCEBERGEN DRUG CORPORATION; HENRY SCHEIN, INC.; GENERAL INJECTABLES & VACCINES, INC.; INSOURCE, INC.; CVS HEALTH CORPORATION; CVS PHARMACY, INC.; CVS TN DISTRIBUTION, L.L.C.; WALGREENS BOOTS ALLIANCE, INC.; WALGREEN CO.; EXPRESS SCRIPTS HOLDING COMPANY; EXPRESS SCRIPTS, INC; CAREMARK RX, L.L.C.; CAREMARKPCS HEALTH, L.L.C.; CAREMARK, L.L.C.; UNITEDHEALTH GROUP INCORPORATED; OPTUM, INC.; OPTUMRX, INC.; and DOES 1-100, Defendants. ii PLAINTIFF’S ORIGINAL COMPLAINT Plaintiff, the City of Norton, Virginia, by and through the undersigned attorneys, (hereinafter
    [Show full text]
  • Complaint (PDF)
    Case 3:17-cv-02375-JCS Document 1 Filed 04/26/17 Page 1 of 16 1 JEE YOUNG YOU (State Bar No. 241658) Email: [email protected] 2 ARNOLD & PORTER KAYE SCHOLER LLP Three Embarcadero Center, 10th Fl. 3 San Francisco, CA 94111-4024 Telephone: (415) 471-3364 4 Facsimile: (415 ) 471-3400 5 Attorneys for Defendants PFIZER INC. and GREENSTONE LLC. 6 7 UNITED STATES DISTRICT COURT 8 FOR THE NORTHERN DISTRICT OF CALIFORNIA 9 KRYSTYNE LOPEZ, Case No. 17-2375 10 Plaintiff, NOTICE OF REMOVAL BY 11 DEFENDANTS PFIZER INC., AND v. GREENSTONE LLC 12 PFIZER, INC., GREENSTONE LLC, 13 MCKESSON CORPORATION, and DOES 1-50, 14 Defendants. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 NOTICE OF REMOVAL Case 3:17-cv-02375-JCS Document 1 Filed 04/26/17 Page 2 of 16 1 TABLE OF CONTENTS 2 Page 3 I. JURISDICTION .....................................................................................................................1 4 A. There is Complete Diversity of Citizenship Between All Properly Joined Parties...........................................................................................................................1 5 6 B. The Amount-in-Controversy is Satisfied .....................................................................2 7 II. REMOVAL IS PROPER BECAUSE MCKESSON IS FRAUDULENTLY JOINED................................................................................................................................... 4 8 A. There is No Factual Predicate that McKesson Distributed the Drug Plaintiff 9 Allegedly Used.............................................................................................................5
    [Show full text]
  • Manufacturers and Wholesalers Street City ST Zip Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Laboratories 100 Abbott Park Road, Dept
    2018 AB128 Code of Conduct Compliant Companies report Manufacturers and Wholesalers Street City ST Zip Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Laboratories 100 Abbott Park Road, Dept. EC10, Bldg. APGA-2 Abbott Park IL 60064 Abbott Molecular Division Abbott Nutrition Products Division Abbott Vascular Division AbbVie, Inc. 1 N. Waukegan Road North Chicago IL 60064 Acadia Phamaceuticals 3611 Valley Centre Drive, Suite 300 San Diego CA 92130 Accelero Health Partners, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Accutron Inc. Ace Surgical Supply, Inc. 1034 Pearl St. Brockton MA 02301 Acell, Inc. 6640 Eli Whitney Drive, Suite 200 Columbia MD 21046 Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne PA 19087 Acorda Therapeutics, Inc. 420 Sawmill River Road Ardsley NY 10532 AcriVet Inc. Actelion Pharmaceuticals US, Inc. 5000 Shoreline Court, Suite 200 S. San Francisco CA 94080 Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 750 Emeryville CA 94608 A-Dec, Inc. 2601 Crestview Dr. Newberg OR 97132 Advanced Respiratory, Inc. Advanced Sterilization Products Services, Inc. Aegerion Pharmaceuticals, Inc. One Main Street, Suite 800 Cambridge MA 02142 Aerie Pharmaceuticals, Inc. 2030 Main St., Suite 1400 Irvine CA 92614 Aesculap Implant Systems, Inc. Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesthera Corporation Afaxys, Inc. PO Box 20158 Charleston SC 29413 AGMS Inc. Akrimax Pharmaceuticals, LLC 11 Commerce Drive, 1st Floor Cranford NJ 07016 Alamo Pharma Services, Inc. Alcon Laboratories, Inc. 6201 South Freeway Fort Worth TX 76134 Alden Optical Laboratories, Inc. Aldenex Vision LLC Alimera Sciences, Inc. 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 Alkermes, Inc.
    [Show full text]